ADAMTS13 and thrombotic thrombocytopenic purpura: The fact that the activity of WT ADAMTS‐13 is dependent, at least in part, on its conformational activation may be an important consideration, as the recombinant protein may be useful as a potential therapy for thrombotic thrombocytopenic purpura 31, 32 and ischemic stroke 20.